RAB42 and glioma: RAB42 was still identified as an independent prognostic factor in a multivariable analysis (HR = 1.222; 95% CI= 1.100–1.357; P < 0.001), implying that it could be a powerful indicator of prognosis in glioma portending poor prognosis (Figure 2C).